Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

A Survey of Virtual Reality Interventions for Autistic Spectrum Disorder Therapy: A Neuroscience Perspective

Author:Allison, Dana   Prelock, Patricia   

Session Name:P1: Behavioral and Cognitive Neurology: Genetics and Clinical Translational Studies in Cognition 1  

Topic:Behavioral and Cognitive Neurology  

Program Number:P1.006  

Author Institution:University of Vermont Larner College of Medicine, Atlanta, GA  University of Vermont College of Nursing and Health Sciences, Burlington, VT  

Efgartigimod for Pembrolizumab-induced Myasthenia Gravis Refractory to Standard Therapy

Author:Campbell, Maryellen   Rodriguez-Hernandez, Adrian   Rizvi, Zufe   Swerdloff, Marc   Zakin, Elina   Faktorovich, Svetlana   

Session Name:P1: Neuromuscular Disease: Neuromuscular Junction Disorders 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P1.006  

Author Institution:Florida Atlantic University, Charles E. Schmidt College of Medicine, Boca Raton, FL  Marcus Neuroscience Institute, Boca Raton, FL  NYU School of Medicine, New York, NY  

Serum NfL in MS Patients Treated with Cladribine: Course and Predictive Value

Author:Moser, Tobias   Seiberl, Michael   

Session Name:P1: MS Biomarkers  

Topic:MS and Inflammatory Disease  

Program Number:P1.006  

Author Institution:Department of Neurology, Christian Doppler University Hospital, Paracelsus Medical University and Center for Cognitive Neuroscience, Salzburg, Austria  

Horner’s Syndrome as an Atypical Presentation of Neuroborreliosis: A Case Report and Review of Literature

Author:Bou Reslan, Sarah   Park, George   Sabadia, Sakinah   Grossman, Scott   Zakin, Elina   

Session Name:P1: Neuro-ophthalmology/Neuro-otology: Case Reports  

Topic:Neuro-ophthalmology/Neuro-otology  

Program Number:P1.006  

Author Institution:New York University, Langone Health, Brooklyn, NY  New York University, Langone Health, New York, NY  

Subgroup outcomes from RAISE: A randomized, Phase 3 trial of zilucoplan in generalized myasthenia gravis

Author:Weiss, Michael D.   Bresch, Saskia   Freimer, Miriam   Hewamadduma, Channa   Juntas-Morales, Raul   Leite, M. Isabel   Maniaol, Angelina   Masuda, Masayuki   Sivakumar, Kumaraswamy   Zajda, Malgorzata   Boroojerdi, Babak   Duda, Petra W.   De La Borderie, Guillemette   Howard Jr., James F.   

Session Name:P1: Autoimmune Neurology: Myasthenia Gravis  

Topic:Autoimmune Neurology  

Program Number:P1.006  

Author Institution:University of Washington Medical Center, Department of Neurology, Seattle, WA  Centre Hospitalier Universitaire de Nice, Nice, France  The Ohio State University, Columbus, OH  University of Sheffield, Sheffield, United Kingdom  Vall d’Hebron University Hospital, Barcelona, Spain  Nuffield Department of Clinical Neurosciences - University of Oxford, Oxford, United Kingdom  Oslo University Hospital, Oslo, Norway  Tokyo Medical University, Tokyo, Japan  University of Arizona, School of Medicine, Neuromuscular Clinic and Research Center, Phoenix, AZ  Medical University of Warsaw, Warsaw, Poland  UCB Pharma, Monheim, Germany, Monheim, Germany  UCB Pharma, Cambridge, MA, USA, Cambridge, MA  UCB Pharma, Brussels, Belgium, Saint Cloud, France  The University of North Carolina, Chapel Hill, NC